OSI Systems Reports Third Quarter Fiscal 2016 Financial Results
-
Q3 Sales of
$211 million -
Q3 Earnings Per Diluted Share
-
Non-GAAP EPS of
$0.64 -
GAAP EPS of
$0.47
-
Non-GAAP EPS of
- Company Authorizes Additional 1,000,000 Share Stock Repurchase Program
"Our third quarter results were largely in line with expectations and
were driven by the overall strength of our Security Division and
continued operating margin expansion in our Optoelectronics and
Manufacturing Division. We were disappointed with the results of our
Healthcare Division as topline challenges continued due to an
unfavorable environment. While the difficult global market continues to
challenge each of our businesses, our backlog and pipeline of
opportunities remain robust and our management team is focused on
setting the stage for a strong start to fiscal 2017," said
The Company reported revenues of
For the nine months ended
As of
Stock Repurchase Program
The Company announced that its Board of Directors has approved a new stock repurchase program authorizing the purchase of up to one million shares of the Company's common stock. The shares of common stock authorized to be repurchased under the new repurchase program are in addition to the 63,158 shares remaining under the Company's existing stock repurchase program.
"Our Board of Directors and senior management are confident in the
Company's growth prospects, cash flow profile and long-term strategy,"
said
Purchases may be made from time to time in the open market or in privately negotiated transactions and block trades, in accordance with federal securities laws, including Rule 10b-18 promulgated under the Securities Exchange Act of 1934, as amended. This program does not have an expiration date. The stock repurchase program may be modified, terminated or expanded by the Company at any time without prior notice. There is no guarantee as to the exact number of shares, if any, that will be purchased by the Company under the program. The amount and timing of any purchases will depend on a number of factors, including price, trading volume, general market conditions, legal requirements, and other factors.
Fiscal Year 2016 Fourth Quarter Outlook
Based on the information known as of today, the Company is reducing its
fiscal 2016 guidance. Fourth quarter sales guidance is
Presentation of Non-GAAP Financial Measures
This earnings release includes a presentation of non-GAAP net income and diluted earnings per share, each of which is a non-GAAP financial measure. Discussion of adjustments to arrive at non-GAAP figures for the three and nine months ended March 31, 2015 and 2016 is provided to allow for the comparison of underlying earnings, net of impairment, restructuring and other charges. Management believes that providing these non-GAAP figures provides additional insight into the ongoing operations of the Company. Non-GAAP financial measures should not be considered in isolation or as a substitute for measures of financial performance prepared in accordance with GAAP. Management believes that these non-GAAP financial measures provide meaningful supplemental information regarding the Company's results primarily because they exclude amounts that management does not view as reflective of ongoing operating results when planning and forecasting and when assessing the performance of the business. Management believes that the Company's non-GAAP financial measures also facilitate the comparison of results for current periods and guidance for future periods with results for past periods.
Reconciliations of GAAP to non-GAAP net income and diluted earnings per share are in the accompanying tables.
Conference Call Information
About
Forward-Looking Statements
This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995, Section
27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended. Forward-looking statements
relate to the Company's current expectations, beliefs, projections and
similar expressions concerning matters that are not historical facts and
are not guarantees of future performance. Forward-looking
statements involve uncertainties, risks, assumptions and contingencies,
many of which are outside the Company's control and which may cause
actual results to differ materially from those described in or implied
by any forward-looking statement. Forward-looking statements include,
but are not limited to, information provided regarding expected
revenues, earnings and growth in fiscal 2016 and fiscal 2017. In
addition, the Company could be exposed to a variety of negative
consequences as a result of delays related to the award of domestic and
international contracts; delays in customer programs; delays in revenue
recognition related to the timing of customer acceptance; unanticipated
impacts of sequestration and other
|
||||||||||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS | ||||||||||||||||
(in thousands, except per share data) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||
2015 | 2016 | 2015 | 2016 | |||||||||||||
Revenues | $ | 215,375 | $ | 210,804 | $ | 691,601 | $ | 608,193 | ||||||||
Cost of goods sold | 142,771 | 140,745 | 455,481 | 402,099 | ||||||||||||
Gross profit | 72,604 | 70,059 | 236,120 | 206,094 | ||||||||||||
Operating expenses: | ||||||||||||||||
Selling, general and administrative | 37,970 | 39,233 | 130,046 | 122,767 | ||||||||||||
Research and development | 12,559 | 12,945 | 38,469 | 37,871 | ||||||||||||
Impairment, restructuring and other charges | 3,620 | 4,537 | 6,425 | 15,634 | ||||||||||||
Total operating expenses | 54,149 | 56,715 | 174,940 | 176,272 | ||||||||||||
Income from operations | 18,455 | 13,344 | 61,180 | 29,822 | ||||||||||||
Interest and other expense, net | (812 | ) | (666 | ) | (2,508 | ) | (2,083 | ) | ||||||||
Income before income taxes | 17,643 | 12,678 | 58,672 | 27,739 | ||||||||||||
Provision for income taxes | 4,415 | 3,335 | 15,954 | 7,483 | ||||||||||||
Net income | $ | 13,228 | $ | 9,343 | $ | 42,718 | $ | 20,256 | ||||||||
Diluted earnings per share | $ | 0.64 | $ | 0.47 | $ | 2.08 | $ | 1.00 | ||||||||
Weighted average shares outstanding - diluted |
20,529 | 19,941 | 20,515 | 20,261 | ||||||||||||
CONSOLIDATED BALANCE SHEETS |
||||||
(in thousands) |
||||||
|
(Unaudited) |
|||||
Assets | ||||||
Cash and cash equivalents | $ | 47,593 | $ | 97,425 | ||
Accounts receivable, net | 178,519 | 159,787 | ||||
Inventories | 230,421 | 291,092 | ||||
Other current assets | 84,988 | 96,523 | ||||
Total current assets | 541,521 | 644,827 | ||||
Non-current assets | 438,153 | 430,475 | ||||
Total Assets | $ | 979,674 | $ | 1,075,302 | ||
Liabilities and Stockholders' Equity | ||||||
Bank lines of credit | $ | -- | $ | 125,000 | ||
Current portion of long-term debt | 2,801 | 2,759 | ||||
Accounts payable and accrued expenses | 114,525 | 146,097 | ||||
Deferred revenues | 47,787 | 34,796 | ||||
Other current liabilities | 84,168 | 97,331 | ||||
Total current liabilities | 249,281 | 405,983 | ||||
Long-term debt | 8,556 | 6,770 | ||||
Deferred income taxes | 65,435 | 68,887 | ||||
Other long-term liabilities | 74,623 | 61,543 | ||||
Total liabilities | 397,895 | 543,183 | ||||
Total stockholders' equity | 581,779 | 532,119 | ||||
Total Liabilities and Stockholders' Equity | $ | 979,674 | $ | 1,075,302 | ||
SEGMENT INFORMATION | ||||||||||||||||
(in thousands) |
||||||||||||||||
(Unaudited) |
||||||||||||||||
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
2015 | 2016 | 2015 | 2016 | |||||||||||||
Revenues - by Segment: | ||||||||||||||||
Security Division | $ | 99,164 | $ | 110,550 | $ | 349,608 | $ | 300,680 | ||||||||
Healthcare Division | 59,383 | 49,113 | 176,710 | 156,126 | ||||||||||||
Optoelectronics and Manufacturing Division including intersegment revenues | 65,291 | 61,306 | 199,912 | 184,414 | ||||||||||||
Intersegment revenues elimination | (8,463 | ) | (10,165 | ) | (34,629 | ) | (33,027 | ) | ||||||||
Total | $ | 215,375 | $ | 210,804 | $ | 691,601 | $ | 608,193 | ||||||||
Operating income (loss) - by Segment: | ||||||||||||||||
Security Division (1) | $ | 13,266 | $ | 14,554 | $ | 50,926 | $ | 29,723 | ||||||||
Healthcare Division (2) | 3,707 | (188 | ) | 11,258 | 6,130 | |||||||||||
Optoelectronics and Manufacturing Division (3) | 5,008 | 5,325 | 13,701 | 14,078 | ||||||||||||
Corporate (4) | (3,498 | ) | (6,077 | ) | (13,748 | ) | (19,182 | ) | ||||||||
Eliminations | (28 | ) | (270 | ) | (957 | ) | (927 | ) | ||||||||
Total | $ | 18,455 | $ | 13,344 | $ | 61,180 | $ | 29,822 | ||||||||
(1) |
Includes impairment, restructuring and other charges of |
|
(2) |
Includes impairment, restructuring and other charges of |
|
(3) |
Includes impairment, restructuring and other charges of |
|
(4) |
Includes impairment, restructuring and other charges of |
|
Reconciliation of GAAP to Non-GAAP Net Income and Earnings Per Share | ||||||||||||||||||||||||
(in thousands, except earnings per share data) |
||||||||||||||||||||||||
(Unaudited) |
||||||||||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
2015 | 2016 | 2015 | 2016 | |||||||||||||||||||||
Net income | EPS | Net income | EPS | Net income | EPS | Net income | EPS | |||||||||||||||||
GAAP basis | $ | 13,228 | $ | 0.64 | $ | 9,343 | $ | 0.47 | $ | 42,718 | $ | 2.08 | $ | 20,256 | $ | 1.00 | ||||||||
Add back - Impairment, restructuring and other charges, net of tax | 2,714 | 0.14 | 3,344 | 0.17 | 4,678 | 0.23 | 11,417 | 0.56 | ||||||||||||||||
Non-GAAP basis | $ | 15,942 | $ | 0.78 | $ | 12,687 | $ | 0.64 | $ | 47,396 | $ | 2.31 | $ | 31,673 | $ | 1.56 | ||||||||
View source version on businesswire.com: http://www.businesswire.com/news/home/20160427006556/en/
Vice President,
Business Development
(310) 349-2237
avashishat@osi-systems.com
Source:
News Provided by Acquire Media